A new radiofrequency thermal balloon catheter for pulmonary vein isolation  by Tanaka, Kazushi et al.
A New Radiofrequency Thermal
Balloon Catheter for Pulmonary Vein Isolation
Kazushi Tanaka, MD, Shutaro Satake, MD, Shigeru Saito, MD, FACC, Saeko Takahashi, MD,
Yoshitaka Hiroe, MD, Yusuke Miyashita, MD, Shinji Tanaka, MD, Michio Tanaka, MD,
Yoshio Watanabe, MD, FACC
Kamakura and Tokyo, Japan
OBJECTIVES We sought to evaluate whether porcine pulmonary vein (PV) isolation (PVI) can be produced
by ablation using our novel radiofrequency (RF) thermal balloon catheter (RBC).
BACKGROUND It has been proposed that PVI can prevent focal atrial fibrillation (AF) originating in or close
to the PV.
METHODS The RBC is composed of a 12F main shaft, a 4F inner tube and a balloon. Inside the balloon,
there is a unipolar coil electrode with a thermocouple sensor mounted along the tube, the
former to deliver RF energy (13.56 MHz) and the latter to monitor the temperature. After
the presence of a PV potential was confirmed, the RBC was safely inserted into the left atrium
(LA) by the trans-septal approach. Once the balloon was inflated and optimally wedged at the
junction between the PV and LA, RF energy was applied for 5 min. Radiofrequency catheter
ablation (RFA) was repeated up to three times, until elimination of the PV potential or
dissociation between the LA and PV was observed. Finally, each heart was examined
histologically.
RESULTS In 18 PVs that had PV potentials, PVI was performed, resulting in success in 15 (success rate
83%, 95% confidence interval [CI] 58.0% to 96.3%; failure rate 17%, 95% CI 3.7% to 42.0%).
After successful PVI, the PV potentials completely disappeared and the histologic examina-
tion revealed circumferential, transmural necrosis around the PV trunks. No major early
complications, such as PV stenosis or macroscopic thrombosis, were observed.
CONCLUSIONS The RBC was useful for PVI. (J Am Coll Cardiol 2001;38:2079–86) © 2001 by the
American College of Cardiology
Recently, it has been shown that paroxysmal atrial fibrilla-
tion (AF) originating from one or more foci is amenable to
a radical cure by radiofrequency catheter ablation (RFA)
(1–5). Except for a few cases (6–11), the vast majority of
these initiating foci are said to be clustered at the ostium or
within the first few centimeters of the pulmonary veins
(PVs) (2,5,12). This concept is supported by the fact that
application of radiofrequency (RF) energy within a PV
successfully terminated AF (1–5,12). However, RFA within
the PVs does not completely prevent the recurrence of AF,
and it occasionally induces PV stenosis, with resultant
pulmonary hypertension (1,2,13–15). To avoid these com-
plications, the creation of a transmural and circumferential
lesion around the PV ostium—namely, pulmonary vein
isolation (PVI) from the left atrium (LA)—is considered a
good alternative (16). However, it is often difficult and
time-consuming to achieve effective PVI with conventional
ablation catheters, although it has been done by a few
selected groups (16), even when an electroanatomic map-
ping system is utilized (17). For this reason, we tried to
devise a novel ablation catheter in which the tip is equipped
with an RF thermal balloon so that general electrophysiolo-
gists could easily and safely create a circumferential lesion
around the PV ostium.
The aim of this study was to electrophysiologically and
histologically evaluate whether RFA using this special
radiofrequency thermal balloon catheter (RBC) could suc-
cessfully induce PVI in porcine hearts.
METHODS
All experiments were performed in accordance with the
Guidelines for Animal Experimentation at Shonan Ka-
makura General Hospital.
New device and animal experiment. This original RBC
(Satake Balloon, Toray Industries, Inc., Tokyo, Japan) is
mechanically similar to the one we previously invented for
coronary angioplasty (SST Balloon Catheter, Japan Cres-
cent) (18,19). Its structure and usage are as follows: the
instrument is composed of a 12F main, flexible lumen shaft
containing a 4F inner tube and a balloon at the tip. The
inner tube can be slid into the main shaft. A 0.035-in. guide
wire is inserted into the central lumen of the tube, through
which a contrast medium can be injected. In the space
between the inner tube and the main shaft, there are
Teflon-coated leads, which are connected to the thermal
monitoring system and the RF current generator, and a tube
with a turncock used to dilate the balloon with fluid. The tip
is equipped with an oval-shaped, semi-compliant balloon
with an inflated diameter of 1.5, 2.0, 2.5 or 3.0 cm, which
is fixed between the distal end of the main shaft and that of
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the inner tube (Fig. 1). The balloon membrane, the shaft
and the tube are made of heat-proof, antithrombotic resin.
A unipolar electrode filament is coiled around the inner tube
inside the balloon to deliver RF energy, along which a
thermocouple sensor is mounted to monitor the intra-
balloon temperature during the energy delivery. In 11
porcine hearts, we examined whether RFA using this RBC
could create PVI. In these animals, the PVI procedure was
performed under artificial ventilation and general anesthesia
with intravenous pentobarbiturate. Heparin was adminis-
tered after a successful transseptal puncture. An intravenous
dose of 100 U/kg body weight, followed by repeated
injections of 1,000 U, was used to keep the activated clotting
time at 300 s during the procedure.
Electrophysiologic study and RFA procedure. The pro-
cedure was as follows: First, the right internal jugular vein
and the right femoral vein were punctured, into which two
6F sheaths were inserted. In addition, a 14F sheath was
introduced into the right femoral vein for the transseptal
approach. A pulmonary venogram was obtained during the
venous phase after injection of a contrast medium into the
right atrium through a 5F angiographic catheter inserted
into the femoral vein. The angiogram was continuously
displayed during the procedure to precisely identify the
position and size of the balloon catheter relative to the ostia
of the PVs. Electrophysiologic study was then performed
with two 6F quadripolar electrode catheters (5-mm inter-
electrode distance and 5-mm space between each electrode
pair). Bipolar intracardiac electrograms were recorded at a
filter setting of 30 to 500 Hz, simultaneously with a body
surface electrocardiogram (ECG). Endocardial stimulation
was achieved with the stimulus intensity of twice to three
times the diastolic threshold. One electrode catheter was
inserted into the coronary sinus (CS) through the jugular
vein under fluoroscopic guidance for pacing of and record-
ing from the LA. A second 6F steerable electrode catheter
was advanced into the LA through the transseptal sheath.
This catheter was pushed into a target PV as distally as
possible and then gradually pulled back until a PV potential
could be recorded with the distal bipolar electrode. If no PV
potential was apparent, electrical stimulation from the distal
CS electrode pair was performed with a cycle length slightly
shorter than that during sinus rhythm (20). After the
electrophysiologic study, the PV electrode catheter was
exchanged for an RBC whose balloon diameter was 5 to
10 mm larger than that of the PV ostium. In this system,
even a large balloon up to 3 cm in diameter could be inserted
into the LA through the atrial septum, with a manipulation
technique similar to that performed with an Inoue-balloon
(Toray Industries, Inc., Tokyo, Japan)—namely, by sliding
the inner tube into the main shaft with the balloon deflated.
After the catheter was deployed into the LA and introduced
from the PV ostium into the PV trunk upstream over a
guide wire, the balloon was inflated with 10 ml of fluid
composed of physiologic saline solution and a contrast
medium. Then, determination of whether or not the balloon
was properly wedged at the junction between the LA and
PV was done by fluoroscopically observing that the contrast
medium injected into the PV through the central lumen of
the inner tube did not leak into the LA (Fig. 2). Once
optimal positioning of the balloon was confirmed, RF
current at 13.56 MHz (Medix Generator, Nihon Medix
Co., Ltd., Chiba, Japan) was delivered for 5 min between
the coil electrode inside the balloon and the electric plate
positioned on the body surface. The temperature inside the
balloon was constantly monitored and maintained at 80°C
by regulating the output of RF energy, because the differ-
ence between the temperature of the tissue contacting the
balloon membrane and that at the thermal sensor during
energy delivery remained at20°C (20.2 2.1°C) in earlier
in vitro studies (data not published). This temperature
difference could vary depending on the balloon diameter. To
avoid such variations, the system is devised to keep the
difference fixed by changing reel counts of the coil electrode
according to the balloon size. After RFA was terminated
and the RBC was replaced by the 6F electrode catheter, the
previous stimulation and mapping protocol was repeated.
The procedure was considered successful when either elim-
ination of the PV potential or dissociation between the LA
and PV potentials was confirmed. In contrast, the result was
considered a failure when up to three RF applications could
not induce the aforementioned conditions. The same pro-
tocol was repeated at each PV. Throughout the entire
procedure, the arterial blood pressure was monitored by a
pigtail catheter positioned in the ascending aorta through
the femoral artery. Finally, after the entire procedure was
completed, every heart was excised for gross anatomic and
microscopic examinations.
Statistical analysis. All data are expressed as the mean
value  SD. All data were compared by using the Student
t test. Discrete variables (success or failure of PVI) were
compared by using the Fisher exact test. A p value 0.05
was considered statistically significant.
RESULTS
Superior versus inferior PV. All of the porcine hearts used
in this study showed PVs anatomically dissimilar to human
PVs. The most noteworthy difference was that in porcine
Abbreviations and Acronyms
AF  atrial fibrillation
CI  confidence interval
CSd  coronary sinus distal
ECG  electrocardiogram or electrocardiographic
LAO  left atrium or atrial ostium
PV  pulmonary vein
PVI  pulmonary vein isolation
RBC  radiofrequency (thermal) balloon catheter
RF  radiofrequency
RFA  radiofrequency (catheter) ablation
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hearts, there were superior and inferior PV trunks, each one
branching off rightward and leftward. In all 11 pigs, the
trans-septal approach was successful. However, two pigs
were excluded from data analysis, because in those two
hearts, it was not possible to record any spike potentials
from the PVs. In the remaining nine animals, weighing
between 36 and 41 kg (mean 38 kg), PVI was carried out
(Table 1). Balloons with a diameter of 2.0 cm were applied
to pig nos. 1 to 3, and 1.5-cm balloons were used in the
remaining six pigs, according to the diameters of the PV
ostia measured angiographically. Pulmonary vein isolation
was successfully achieved in 15 of the 18 PVs (success rate
83%, 95% confidence interval [CI] 58.0% to 96.3%),
whereas in the remaining 3 PVs (1 superior and 2 inferior
PVs), the procedure was unsuccessful (failure rate 17%, 95%
CI 3.7% to 42.0%). Although the success rate was higher in
superior compared with inferior PVs, the difference did not
reach statistical significance (89% vs. 78%, p  0.99). The
maximal output of the RF energy required to keep the
intraballoon temperature at 80°C tended to be lower in the
superior PVs (117 25 W) than in the inferior PVs (128
44 W). The difference was not statistically significant (p 
0.52), however. Regarding the number of RF energy deliv-
eries required in the superior PV, successful PVI was
achieved by the first RFA in six pigs and by the second RFA
in two pigs (nos. 1 and 3). In the remaining pig (no. 9),
successful PVI was not accomplished by three RFA appli-
cations (Table 1). In contrast, in the inferior PV, the first
Figure 1. The radiofrequency transballoon ablation catheter used in this study. (Top) Photograph of a balloon 1.5 cm in diameter, inflated with fluid and
equipped near the distal end of the catheter. A coil electrode with a thermocouple sensor is mounted along the tube inside the balloon. (Bottom) This
schematic illustration shows the balloon being wedged at the junction between the pulmonary vein and left atrium. The body of the catheter is 90 cm in
length, and a 12F main shaft containing a 4F inner tube, as well as its central lumen, can accept a 0.035-in. guide wire. Shaded areas represent the ablated
sites located at the pulmonary vein ostium. See text for details. RF  radiofrequency.
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ablation was successful in six pigs and the second ablation in
one pig (no. 4), whereas all attempts failed in the other two
pigs (nos. 1 and 2). Thus, a slightly greater number of RF
energy deliveries were needed in inferior PVs as compared
with superior PVs, but the difference was insignificant
(1.6  0.9 and 1.4  0.7, respectively; p  0.77). These
insignificant differences may have resulted from the small
number of pigs.
Arterial blood pressure dropped from a mean of 102 mm
Hg to a mean of 83 mm Hg during the balloon inflation,
but was restored to initial values immediately after the
catheter was pulled back. During balloon inflation, the heart
rate remained essentially unchanged, although a few atrial
premature beats, probably originating from the PV ostium,
were occasionally observed.
Electrophysiologic isolation of PVs from the LA. Before
RFA, a dissociation between the LA and PV potentials was
not observed in any PV. In 15 (8 superior and 7 inferior) of
18 PVs, elimination of the PV potential was observed after
RFA, but a dissociation between the LA and PV potentials
could not be demonstrated (Fig. 3). Figure 3 shows a
representative successful example. The left and right panels
show surface ECG and intracardiac recordings obtained
before and after PVI, respectively. In each panel, the records
show, from top to bottom, ECG leads I and II and
intracardiac electrograms from the CS and superior PV.
Before ablation, pacing from the coronary sinus-distal
(CSd) was helpful to separate PV potentials (upward ar-
rows) from a preceding low-amplitude, far-field atrial po-
tential in the pulmonary vein-distal (PVd) electrogram (20),
revealing that the stimuli were propagated to the PV in a
one-to-one fashion. In the pulmonary vein-ostium (PVo)
record, however, two deflections are noted—a larger one
representing the LA and a smaller one representing ventric-
ular activation—but no PV potential is observed. After
ablation, the PV potential was no longer recorded, even on
the PVd electrogram during sinus rhythm (right panel) and
during CSd stimulation (not shown). Moreover, the ampli-
tude of atrial potential recorded on the PVo electrogram
decreased. These findings indicate that PVI eradicated all
the potentials within the superior PV (4) and brought about
moderate damage to the LA myocardium around the PVo.
Of course, to draw such a conclusion, one must make certain
that the position of the PVo catheter remained unchanged
before and after the ablation. This was verified by careful
fluoroscopic observations. The average time required to
finish the entire procedure was 2.1  0.4 h (range 1.5 to
3.0 h), including the fluoroscopy exposure of 25  9 min
(range 14 to 37 min).
Pathologic isolation. In all 15 PVs in which successful
PVI was achieved, circumferential, transmural necrosis
around the PVo was histologically demonstrated (Fig. 4 and
5). In the remaining three PVs in which PVI was unsuc-
cessful, noncircumferential or nontransmural necrosis, cor-
responding to the ablated area, was observed.
Figure 4 shows macroscopic findings in the endocardial
site near the PVo after successful PVI. The ablated lesion
was relatively well demarcated with brownish discoloration
located at the junction between the LA and the superior and
inferior PV trunks. No major early complications, such as
LA or PV perforation, PV stenosis or massive clot forma-
tion, were observed after the PVI procedure. Figure 5 shows
histologic specimens in Azan stain from the identical site as
shown in Figure 4. The upper, middle and lower panels in
Figure 5 represent low, intermediate and high magnifica-
tions, respectively. In the upper panel, transmural coagula-
tion necrosis is noted in the LA myocardium, partly
involving the atrial myocardial extension into the PV trunk.
Moreover, in the middle panel, not only does contraction
band necrosis surround the region of coagulation necrosis,
but also endocardial and connective tissues show degenera-
tive changes (up to 3.5 mm in depth). Edema and mild
hemorrhage are frequently observed in the tissue surround-
ing the ablated area, as well. A minimal amount of fresh
thrombus is detected on the ablated endocardium. The
lower panel shows that RFA caused coagulation necrosis of
myocardial fibers in the LA. There was no damage to the
lung tissue, the esophagus or the aorta.
DISCUSSION
Major findings. To the best of our knowledge, this is the
first study in which successful PVI using an RBC was both
electrophysiologically and histologically confirmed in por-
cine hearts. The newly designed ablation catheter was easily
inserted into any target PV by the transseptal approach and
Figure 2. Fluoroscopically optimal image of the balloon and the inferior
pulmonary vein in the anteroposterior projection. Multiple arrows indicate
the inflated balloon filled with a mixture of saline solution and contrast
medium. An occlusive pulmonary venogram confirms that the balloon is
firmly wedged into the pulmonary vein ring. ABL  ablation; CS 
coronary sinus electrode catheter; PC  pigtail catheter; PV  inferior
pulmonary vein.
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wedged at the junction between the LA and PV trunk by
dilating the semi-compliant balloon with an appropriate
volume of saline and contrast medium. Whenever optimal
contact between the balloon surface and the PV ring was
obtained, it did not take much time, nor many attempts, to
achieve successful PVI without major early complications,
except for microscopic thrombus formation.
Pulmonary vein isolation for termination of AF. As early
as 1980, an intracellular micro-electrode study in isolated
guinea-pig preparations demonstrated the existence of pace-
making activity in the PVs (21). Subsequent electron
microscopic studies of the rat heart confirmed a close
resemblance between the striated muscle of the PV and the
atrial muscle, and further showed that the ultrastructural
characteristics of the cells in the myocardial layer of the PV
were similar to those of the sinus node cells (22). These
results suggest that the myocardial cells located in the PV
may well initiate atrial arrhythmias.
Recently, the myocardial sleeves within all the PVs have
been shown to play an important role in the genesis of
human paroxysmal or persistent AF (1–5). This contention
is substantiated by the fact that AF can be terminated by
ablating the PV suspected of contributing to the initiation
of AF (1,2,10). However, the application of RF energy
within the PV has, at least in certain instances, induced PV
stenosis, leading to pulmonary hypertension (1,13,14). Fur-
thermore, even when Haissaguerre et al. (4) performed
successful PVI at the PVo by using a more segmental
approach, new arrhythmogenic foci did emerge from the
area proximal to the ablated lesion around the PVo (2,4,5).
Table 1. Results of Radiofrequency Ablation
Pig No. BW (kg)
Superior Pulmonary Vein Inferior Pulmonary Vein
MOE (W) No. of EDAs PVI MOE (W) No. of EDAs PVI
1 40 100 2 S 200 3 F
2 41 150 1 S 200 3 F
3 38 150 2 S 150 1 S
4 37 100 1 S 100 2 S
5 38 100 1 S 100 1 S
6 37 100 1 S 100 1 S
7 38 100 1 S 100 1 S
8 36 100 1 S 100 1 S
9 37 150 3 F 100 1 S
Mean  SD 38.0  1.6 117  25 1.4  0.7 89% 128  44* 1.6  0.9* 78%*
*p  NS, compared with superior pulmonary vein.
BW  body weight; EDA  energy delivery attempts; F  failure; MOE  maximal output energy required to keep the
temperature inside the balloon at 80°C; PVI pulmonary vein isolation; S success. Under PVI, 89% and 78% indicate success
rates in superior and inferior pulmonary veins, respectively.
Figure 3. Disappearance of pulmonary vein (PV) “spike” potentials after successful radiofrequency ablation. Surface electrocardiographic leads I and II are
simultaneously recorded with intracardiac electrograms from the coronary sinus (CS) (CSd and CSp [d  distal and p  proximal]) and the PV (PVd and
PVo [o ostium]). (Left) Before ablation, there are PV spike potentials (PV, upward arrows) on the PVd electrogram, which are unmasked and separated
from the preceding low-amplitude, far-field atrial potentials by pacing (S) from the CSd. (Right) After ablation, the PV spikes are no longer seen during
sinus rhythm. Note that the amplitude of the “A” potential in the PVo electrogram decreases. A  atrial potential; V  ventricular potential. See text for
details.
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To prevent the recurrence of AF, circumferential ablation
around the PVo, as proposed by Pappone et al. (16,17), is
considered more useful than the previous methods (1,2,4).
When using conventional ablation catheters, however, it is
often time-consuming and difficult to create a circular lesion
around the PVo, although it has been done by a few groups
(16). Thus, it was considered desirable to develop a special
ablation device for PVI. Natale et al. (23) showed that PVI
using a new ultrasound balloon ablation system was effective
in preventing recurrent human AF without early or late
complications, including PV stenosis. Although our system
may appear similar to theirs, there are two definite differ-
ences—one is the energy source and the other is the
ablation site. Namely, they targeted the PV wall using
ultrasound, whereas we mainly ablated the LA tissue around
the PVo with RF energy.
Mechanism and advantages of the thermal balloon abla-
tion system. MECHANISM. Radiofrequency application at a
very high frequency (13.56 MHz), using this system, pro-
vokes a unique capacitive-type heating all around the coil
electrode inside the balloon, so that the LA tissue in contact
with this balloon is effectively heated (24). In contrast, the
endothelium of the PV distal to the balloon is exposed to
much less heat than is the LA, because the blood surround-
ing the balloon has an impedance too low to be affected by
the capacitive-type heating and is constantly circulating
along with convection. Therefore, the tissue contacting the
Figure 4. Macroscopic findings of the endocardial site after successful
pulmonary vein (PV) isolation. The ablated lesion is relatively well
demarcated (brownish in color) and located near the junction between the
left atrium and PV trunks. Note that the ostia of the superior (S) and
inferior (I) PVs are encircled by the ablated lesion. MA  mitral annulus.
See text for details.
Figure 5. Histologic findings of the identical case as in Figure 4. (Top)
(low magnification): Transmural coagulation necrosis (N) is detected near
the junction (curved portion) between the (LA) and the inferior pulmo-
nary vein (PV) trunk. Atrial myocardial extension (Ex) (about 9 mm in
length) spreads into the PV almost entirely and reaches near the right end
of the panel. Fa  fat tissue; Ao  aorta. (Middle) (intermediate
magnification): Coagulation necrosis (N) in the LA myocardium and
contraction band necrosis (CBN) in the proximal portion of the atrial
myocardial extension into the PV. (Bottom) (high magnification): Coag-
ulation necrosis (N) of muscle fibers located within the ablated LA. All
specimens are in Azan stain.
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balloon surface was selectively ablated (Fig. 1, shaded areas
in lower panel).
ADVANTAGES. The major advantages of our catheter are as
follows: first, once an optimal position of the balloon, with
reference to the PVo, is confirmed by observation of an
occlusive pulmonary venogram, application of RF energy
can effectively produce a transmural circular lesion around
the PVo, resulting in successful ablation of the posterior LA
around the PV ostia and elimination of PV potentials,
without an additional delivery of energy. Moreover, it is
possible that reconditioning of the electrical activity in this
relatively large zone of the LA may eventually succeed in
curing AF. Second, because the interface in direct contact
with the endocardium is not the electrode tip, but rather the
balloon surface, the risk of causing mechanical injury to the
endocardium or perforation is minimized. Finally, the use of
RF energy and antithrombotic material in the balloon
membrane prevents activation of the coagulation factor and
massive clot formation. This merit has already been proven
in coronary angioplasty using our previous RF “hot” bal-
loons (18,19).
Study limitations. Admittedly, this study has several lim-
itations. First, precise information is not available on the
temperature of the interface between the PV and the
balloon during RF application. However, it is known that
the difference between the temperature of the interface in
contact with the balloon surface and that inside the balloon
during RF application is 20°C, as determined in earlier in
vitro studies (data not published). Second, if a direct
connection between the atrial tissue and the distal portion of
the PV were indeed present in some human hearts (25),
even successful PVI procedures might not eradicate focal
AF. Third, it has not been evaluated whether the PVI
procedure could cause a persistent disturbance of mechan-
ical atrial function (26), including a left-to-right shunt, or
adversely affect the secretion of atrial natriuretic peptide
hormone (27), as in the case of multiple linear RF lesions,
although a hemodynamic disturbance was not observed
during the early phase of the present study. Finally, it is
unknown whether complete isolation of the LA and PVs
could somehow create a new arrhythmogenic substrate for
macro-reentrant atrial tachyarrhythmias, such as LA flutter
(28). To solve this problem, further studies must be con-
ducted on the need of an additional ablation line connecting
the PV and the mitral annulus (17,29,30).
Clinical implications. In this experiment, 5 min was
adopted as the RF delivery time. This is because we wanted
to clearly demonstrate the effect of capacitive-type heating
on the tissue. However, the pathologic examination showed
excessive damage to the LA myocardium. Hence, in the
clinical setting, we would limit the duration of RF energy
application to 2 to 3 min. We are now improving the RBC
system by reducing the diameter of the shaft and the
temperature difference between the thermocouple sensor
and the contacting tissue by changing the shape of the
balloon.
Conclusions. We have demonstrated, both electrophysi-
ologically and histologically, that RFA using our novel
thermal balloon system is feasible for the creation of
circumferential lesions around porcine PV rings, without
major early complications. We expect that this system
would be a new tool for the treatment of patients with
paroxysmal AF originating in the PV or around the PV
ostium, or both.
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